Data entry and imports |
The CARRA Registry has for FDA 21CFR11 compliant site data entry using an electronic data capture system and, at certain sites, electronic health record data transfer. |
Subjects are consented at each site. |
Contact information and copies of informed consents are maintained in the Consent and Contact Database that is managed by the Long-Term Follow-up Group at the DCRI. |
Access to clinical data and contact data are separated by a Personal Identifiers Firewall (at both organizational and electronic levels) to ensure privacy and protect the usage of contact and personal health information. |
Patient-reported outcomes and surveys are collected and entered into the electronic data system or entered directly by subjects. |
Data exports |
Imported data are securely routed to site-specific i2b2 datamarts corresponding to the originating sites. |
Multiple virtual i2b2 databases are hosted on a central i2b2 server “farm,” allowing scalability to add sites, other sources of data entry, or specific projects such as CARRA-CoRe. |
Permissioned sharing of data is governed through the Shared Health Research Information Network. |
The CARRA Registry i2b2-Self Scaling Registry Query Aggregator and User Interface permits each site to query its own CARRA Registry data. |
Permissioned investigators can perform network queries to access and analyze aggregated data across 2 or more network sites. |
CARRA-CoRe has a virtual i2b2 datamart incorporating data imports from the CARRA Registry with additional CARRA-CoRe-specific fields. |
Additional data from review of medical records for serious adverse events or prespecified important medical events are entered into the CARRA-CoRe datamart. |
Additional linked data sources are added as appropriate to the CARRA-CoRe requirements. |
CARRA-CoRe queries can provide multiple opportunities for primary and secondary analyses relevant to pharmacoepidemiology, adverse events, medication safety, and other areas of interest. |